版本:
中国

FDA places clinical hold on Concert Pharma's hair loss drug

May 17 Concert Pharmaceuticals Inc said on Wednesday the U.S. Food and Drug Administration imposed a clinical hold on a mid-stage trial testing the company's drug to treat alopecia areata, a type of hair loss.

The agency did not cite any concerns about the drug's safety, Concert Pharma said. (Reporting by Divya Grover in Bengaluru; Editing by Sai Sachin Ravikumar)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐